Key facts
- This page summarizes Timothy Ray Knowles's Form 4 filing for KULR Technology Group, Inc. (KULR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 Mar 2024, 21:45.
Timothy Ray Knowles - 25 Mar 2024 Form 4 Insider Report for KULR Technology Group, Inc. (KULR)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- KULR
- Reported as of
- 25 Mar 2024
- Net transaction value
- -$104,788
- SEC form
- 4
- Accepted by SEC
- 27 Mar 2024, 21:45:41 UTC
- Prior SEC filing
- 22 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Timothy Knowles
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Timothy Ray Knowles filed Form 4 for KULR Technology Group, Inc. (KULR) on 27 Mar 2024.
Change
- Previous filing in this sequence was filed on 22 Mar 2024.
- Current net transaction value: -$104,788.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KULR
transaction
Common Stock
Sale
- Transaction value
- $104,788
- Shares
- -361,338
- Change %
- -2.5%
- Price
- $0.2900
- Shares after
- 14,268,027
- Date
- 25 Mar 2024
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Dr. Knowles, in order to make proceeds available for extraordinary medical expense obligations, sold shares pursuant to the limitations set forth in Rule 144(e) with respect to the amount of securities eligible for sale during any three month period.
Footnote F2
On March 25, 2024, Dr. Knowles sold 361,338 shares of Issuer's common stock (the maximum number of shares remaining under the Rule 144(e) limitation) at an average price of $0.294427 per share. Upon request by the Commission, the Reporting Person shall provide full information regarding the number of shares sold at each separate price.
Footnote F3
The number of shares of common stock beneficially owned following the reported transactions does not include Dr. Knowles' indirect ownership of over 670,360 shares owned by his spouse, Marianne Knight. Dr. Knowles does not have direct voting or dispositive control over the shares owned by Ms. Knight.